83% is a fantastic result esp. when you factor in half of all patients were on placebo and would not have been feeling any benefits. Would loved to have been a fly on the wall when placebo patients were briefed on why they should/could extend.
Also interesting how we seem to have slipped back to a tail wagging the dog scenario with ASX sentiment now following NASDAQ. For a couple of years this trend was reversed so re immergence of NASDAQ leading may be a sign of the calibre of investors now taking positions in US.
Tonight's action will be interesting on the back of this latest ann.
imagine extension trial proceeds, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.002(40.0%) |
Mkt cap ! $36.71M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $980.8K | 154.3M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4519008 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 36825074 | 29 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |